Literature DB >> 28776371

Asymmetric Formal Synthesis of the Long-Acting DPP-4 Inhibitor Omarigliptin.

Feng Peng, Yonggang Chen, Cheng-Yi Chen, Peter G Dormer, Amude Kassim, Mark McLaughlin, Robert A Reamer, Edward C Sherer, Zhiguo J Song, Lushi Tan, Matthew T Tudge, Baoqiang Wan1, John Y L Chung.   

Abstract

A highly efficient asymmetric synthesis of the key tetrahydropyranol intermediate of DPP-4 inhibitor omarigliptin (1) is described. The successful development of a protecting-group- and precious-metal-free synthesis was achieved via the discovery of a practical asymmetric Henry reaction and the application of a one-pot nitro-Michael-lactolization-dehydration through-process. Other features of the synthesis include a highly efficient MsCl-mediated dehydration and a crystallization-induced dynamic resolution for exceptional ee and dr upgrade. The synthesis of this complex intermediate utilizes simple starting materials and proceeds in four linear steps.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28776371      PMCID: PMC5933450          DOI: 10.1021/acs.joc.7b01467

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  14 in total

Review 1.  Crystallization-induced diastereomer transformations.

Authors:  Karel M J Brands; Antony J Davies
Journal:  Chem Rev       Date:  2006-07       Impact factor: 60.622

2.  How solvent influences the anomeric effect: roles of hyperconjugative versus steric interactions on the conformational preference.

Authors:  Changwei Wang; Fuming Ying; Wei Wu; Yirong Mo
Journal:  J Org Chem       Date:  2014-01-31       Impact factor: 4.354

3.  Asymmetric synthesis of highly functionalized tetrahydropyran DPP-4 inhibitor.

Authors:  Feng Xu; Michael J Zacuto; Yoshinori Kohmura; Jon Rosen; Andrew Gibb; Mahbub Alam; Jeremy Scott; David Tschaen
Journal:  Org Lett       Date:  2014-09-30       Impact factor: 6.005

Review 4.  Medicinal chemistry of drugs used in diabetic cardiomyopathy.

Authors:  E Adeghate; H Kalasz; G Veress; K Teke
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

5.  A new copper acetate-bis(oxazoline)-catalyzed, enantioselective Henry reaction.

Authors:  David A Evans; Daniel Seidel; Magnus Rueping; Hon Wai Lam; Jared T Shaw; C Wade Downey
Journal:  J Am Chem Soc       Date:  2003-10-22       Impact factor: 15.419

6.  Evaluating the Phase II drugs currently under investigation for diabetic neuropathy.

Authors:  Ernest Adeghate; Erzsébet Fehér; Huba Kalász
Journal:  Expert Opin Investig Drugs       Date:  2014-08-29       Impact factor: 6.206

7.  Diphenylprolinol silyl ether as a catalyst in an asymmetric, catalytic, and direct michael reaction of nitroethanol with alpha,beta-unsaturated aldehydes.

Authors:  Hiroaki Gotoh; Daichi Okamura; Hayato Ishikawa; Yujiro Hayashi
Journal:  Org Lett       Date:  2009-09-17       Impact factor: 6.005

Review 8.  Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.

Authors:  Abd A Tahrani; Anthony H Barnett; Clifford J Bailey
Journal:  Nat Rev Endocrinol       Date:  2016-06-24       Impact factor: 43.330

9.  Omarigliptin (MK-3102): a novel long-acting DPP-4 inhibitor for once-weekly treatment of type 2 diabetes.

Authors:  Tesfaye Biftu; Ranabir Sinha-Roy; Ping Chen; Xiaoxia Qian; Dennis Feng; Jeffrey T Kuethe; Giovanna Scapin; Ying Duo Gao; Youwei Yan; Davida Krueger; Annette Bak; George Eiermann; Jiafang He; Jason Cox; Jacqueline Hicks; Kathy Lyons; Huaibing He; Gino Salituro; Sharon Tong; Sangita Patel; George Doss; Aleksandr Petrov; Joseph Wu; Shiyao Sherrie Xu; Charles Sewall; Xiaoping Zhang; Bei Zhang; Nancy A Thornberry; Ann E Weber
Journal:  J Med Chem       Date:  2014-04-02       Impact factor: 7.446

10.  A new catalyst for the asymmetric Henry reaction: synthesis of β-nitroethanols in high enantiomeric excess.

Authors:  James D White; Subrata Shaw
Journal:  Org Lett       Date:  2012-11-30       Impact factor: 6.005

View more
  1 in total

1.  Two methods for the preparation of sitagliptin phosphate via chemical resolution and asymmetric hydrogenation.

Authors:  Fei Ye; Zhifeng Zhang; Wenxia Zhao; Jianhai Ding; Yali Wang; Xueyan Dang
Journal:  RSC Adv       Date:  2021-01-25       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.